EDARAVONE

Formula & Concentration

EDARAVONE- edaravone injection, solution

Manufacturer

Piramal Critical Care, Inc.

Indications

Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1)

Product Options

Package Size

NDC #

Presentation

30 mg

66794-0259-64

Syringe

Shelf Life and Storage

Store Edaravone Injection at 20º to 25º C (68º to 77º F); excursions permitted from 15° to 30° C (59° to 86 °F) [See USP Controlled Room Temperature]. Protect from light. Store in overwrapped package to protect from oxygen degradation until time of use. The oxygen indicator will turn blue or purple if the oxygen has exceeded acceptable levels. Once the overwrap package is opened, use within 24 hours.